PF-Atlas › Clinical Trials › NCT02465450

Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 in Cystic Fibrosis

JBT-101 · Phase 2

Registry ID

NCT02465450

Phase

Phase 2

Status

Completed

Drug / intervention

JBT-101 (lenabasum)

Sponsor

Corbus Pharmaceuticals Inc.

Start

2015-09-29

About this trial

JBT-101 is evaluated in NCT02465450, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Corbus Pharmaceuticals Inc.. Current status: Completed.

View NCT02465450 on ClinicalTrials.gov →

Explore related

All JBT-101 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02465450 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.